Product Description: Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan is a drug-linker conjugate for ADC. Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan consists of Exatecan (HY-13631) and a linker. Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan can be used for synthesis of ADCs and for cancer research[1].
Applications: Cancer-programmed cell death
Formula: C57H65FN10O15
References: [1]Masuda Takeshi, et al. Preparation of antibody-drug conjugates for cancer therapy. Patent WO2014057687.
CAS Number: 1599439-54-9
Molecular Weight: 1149.18
Compound Purity: 99.09
Research Area: Cancer
Solubility: DMSO : 100 mg/mL (ultrasonic)
Target: Drug-Linker Conjugates for ADC;Topoisomerase